Octave Ventures LLC

What Octave Ventures LLC does

Octave Ventures LLC is a privately-held venture capital firm founded in 2018 by Michael S. Kim and headquartered in Henderson, United States. The firm specializes in global venture investments in deep tech and biotechnology, with a particular emphasis on pre-IPO companies at various stages of development. Its disclosed portfolio of 17 companies spans quantum/computing (Cornami), autonomous sensing (Luminar), AI and robotics (Osaro, Qolab, Plenary.AI), defense/security (Lassen Peak, Red 6, ZeroEyes), and biotech therapeutics (Finch Therapeutics, DD Pharmatech, Neuralymed, Berentx, ValTed Seq), with several portfolio companies having subsequently gone public. Michael S. Kim serves as Founder and CEO and sits on the boards of seven portfolio companies, while Joshua Schwab serves as Partner and COO, bringing cross-border fund formation and structured finance experience from Credit Suisse and Asia-based legal practice.

The firm operates a relationship-driven, direct investment model with limited public-facing marketing; deal sourcing is driven primarily by Kim's three-decade network of corporations, institutional investors, and sovereign wealth funds. Co-investment activity (e.g., the Lassen Peak $10M+ round alongside Structural Capital, Madrona Ventures, Axon Enterprises, and other venture firms) indicates the firm typically takes minority positions in syndicates rather than leading rounds. Revenue is generated through venture capital returns (equity gains and management fees on undisclosed AUM), and the firm recently divested control of Lloyd's Syndicates 4242 and 1416 to Statera Managing Agency in February 2026, narrowing its operational scope to pure venture investing. The firm's competitive position is anchored in the principal-level relationships, board access, and brand association with category-defining names such as Luminar and Palantir, rather than in proprietary technology.

Name

Octave Ventures LLC

Legal name

Octave Ventures LLC

Website

https://octave-ventures.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Octave Ventures is a privately-held US venture capital firm founded in 2018 that makes pre-IPO investments in deep tech and biotech companies globally, with a 17-company portfolio spanning AI, robotics, defense sensing, and therapeutics.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (52394)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Venture capital investing
• Deep tech investments
• Biotech venture capital
• Pre-IPO equity funding
• Growth-stage capital

Headquarters

HQ city

Henderson

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Venture Capital Returns: Octave Ventures generates returns through equity investments in portfolio companies, several of which have later gone public. The firm invests in pre-IPO companies at various stages of their development.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Octave Ventures LLC is a global venture capital firm that makes equity investments in pre-IPO deep tech and biotech companies at various stages of development. The firm partners with founders to provide growth-stage capital, strategic advisory, and board governance, with several portfolio companies having subsequently gone public.

Product overview

Octave Ventures LLC is a global venture capital firm specializing in deep tech and biotech investments. The company makes venture investments in pre-IPO companies at various stages of development, several of which have later gone public. The firm is committed to partnering with founders to foster growth and development of advanced technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Capital Investment

Quantifiable outcome

• Several portfolio companies have later gone public

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Statera Managing AgencyminorStrategic or Co-development Partner · 1 February 2026Statera Managing Agency, a UK-based Lloyd's managing agent associated with specialty insurance and reinsurance, received regulatory approval to operate as a Lloyd's managing agent, shifting control of syndicates 4242 and 1416 in-house from Octave Ventures. The change aims to reduce external dependencies.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• DCVC (Data Collective): Venture capital firm focused on deep tech investments in data, AI, computing, and life sciences. Closely aligned with Octave's deep tech and biotech investment mandate, with similar pre-IPO, multi-stage approach.
• ARCH Venture Partners: Venture capital firm specializing in early-stage deep tech, biotech, and physical sciences companies. Directly comparable in sector focus and stage of investment, particularly within biotech therapeutics and advanced technology.
• Lux Capital: Sector-focused venture capital firm investing in deep tech and scientific breakthrough companies across AI, robotics, space, and biotech. Highly comparable thesis to Octave Ventures' deep tech and biotech focus, though operating at materially larger AUM and team size.
• 1517 Fund: Early-stage venture capital firm supporting young founders building deep tech and science-based companies. Comparable to Octave in deep tech focus and early-stage investment approach, though typically targeting younger founders.
• Section 32: Venture capital firm founded by Bill Maris, investing across biotech, tech, and frontier science. Comparable to Octave in targeting pre-IPO biotech and deep tech with a focus on transformative technologies.
• Obvious Ventures: Venture capital firm investing in purpose-driven companies across multiple technology verticals including deep tech and biotech. Comparable in size and sector-focused thesis to Octave Ventures.

Broad incumbents

• Khosla Ventures: Large, established venture capital firm with a core focus on deep tech and biotech/cleantech. Significantly larger and more diversified than Octave, but the venture-stage, sector-focused thesis makes it a relevant incumbent comparator.
• Allen & Company: Private investment bank focused on principal investing in technology, media, and telecom companies. Comparable in its principal investing approach and deep tech exposure, though operating as a much larger, established firm.
• Founders Fund: Established venture capital firm with significant exposure to deep tech, defense, and biotech investments. Broader portfolio than Octave but overlapping investment categories and stage focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments23 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Octave Ventures LLC